Alterity Therapeutics (ATHE) Depreciation and Depletion (2009 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Depreciation and Depletion of -$73230.5 for Q4 2025, little changed year-over-year from -$73578.2 in Q4 2024, and little changed quarter-over-quarter from -$72886.1 in Q4 2024.
Alterity Therapeutics (ATHE) Depreciation and Depletion (2009 - 2025) Analysis & Trends
Alterity Therapeutics' Depreciation and Depletion history runs 14 years deep, the most recent figure standing at -$73230.5 for Q4 2025.
- In Q4 2025, Depreciation and Depletion changed 0.47% year-over-year to -$73230.5; the TTM figure through Dec 2025 stood at -$258304.3 (down 16.67% YoY), while the FY2025 annual figure was $71349.4, down 100.0% from the prior year.
- Depreciation and Depletion for Q4 2025 stood at -$73230.5, roughly flat from -$72886.1 in the prior quarter.
- The five-year high for Depreciation and Depletion was -$36328.9 in Q4 2021, with the low at -$73230.5 in Q4 2025.
- The 5-year median for Depreciation and Depletion is -$72340.7 (2023), against an average of -$58926.6.
- The sharpest annual moves came in 2023 and 2025: Depreciation and Depletion slumped 81.55% in 2023, then retreated 0.47% in 2025.
- Alterity Therapeutics' Depreciation and Depletion stood at -$36328.9 in 2021, then slipped by 9.68% to -$39847.1 in 2022, then tumbled by 81.55% to -$72340.7 in 2023, then dropped by 0.75% to -$72886.1 in 2024, then fell by 0.47% to -$73230.5 in 2025.
- Business Quant data shows ATHE's Depreciation and Depletion at -$73230.5 in Q4 2025, -$72886.1 in Q4 2024, and -$72340.7 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -73,230.50 |
| Dec 31, 2025 | -73,230.50 |
| Dec 31, 2024 | -72,886.08 |
| Dec 31, 2024 | -72,886.08 |
| Dec 31, 2023 | -72,340.67 |
| Dec 31, 2023 | -72,340.67 |
| Dec 31, 2022 | -39,847.06 |
| Dec 31, 2022 | -39,847.06 |
| Dec 31, 2021 | -36,328.87 |
| Dec 31, 2021 | -36,328.87 |
| Jun 30, 2020 | 56,653.90 |
| Jun 30, 2020 | 56,653.90 |
| Dec 31, 2019 | -39,090.02 |
| Dec 31, 2019 | -39,090.02 |
| Jun 30, 2019 | 20,801.22 |
| Jun 30, 2019 | 20,801.22 |
| Dec 31, 2018 | 10,527.79 |
| Dec 31, 2018 | 10,527.79 |
| Jun 30, 2018 | 165.03 |
| Jun 30, 2018 | 165.03 |